Intertrigo Complicated by Candida Infection — When Topical Antifungals Have Not Resolved the Rash

This page addresses candidal intertrigo — intertrigo in the skin folds complicated by Candida (candidal) infection — specifically in patients where first-line topical antifungal therapy has not achieved rash resolution.

Clinical Scenario

Intertrigo complicated by candidal (Candida) infection. Intertrigo complicated by fungal infection should be managed with topical antifungals; nystatin is effective only for candidal intertrigo. The treatment goal is resolution of the rash in the affected skin folds.

Prior Treatment — Goal Not Achieved

First-line management of candidal intertrigo involves topical antifungals applied twice daily until rash resolution — including agents such as nystatin, clotrimazole, ketoconazole, oxiconazole, or econazole. This protocol applies when that approach has failed to achieve resolution of the rash in the affected skin folds.

Next-Line Treatment Direction

When topical antifungal therapy has not been sufficient, an oral antifungal approach is used for resistant fungal infection. Individual patient factors may influence the regimen selected. The complete protocol — including agent, regimen specifics, and considerations for particular patient profiles — is available via the link below.

Instant Access to Structured Evidence-Based Regimens

References

Intertrigo complicated by fungal infection should be managed with topical antifungals. Nystatin is effective only for candidal intertrigo.

Fluconazole (Diflucan), 100 to 200 mg daily for seven days, is used for resistant fungal infections, although patients who are obese may require an increased dosage.

View source ↗